CD38 and leukemia: They showed that LSC expressed a higher amount of CD82 than CD34+/CD38+ AML cells; these findings suggested that overexpression of CD82 may render LSC able to adhere to the bone marrow (BM) niche where it appears to regulate maintenance of leukemia stem cells within the BM niche.